Inozyme Pharma Inc (INZY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 31,605 | N/A | N/A |
| Marketable Securities | 15,527 | N/A | N/A |
| TOTAL | $47,460 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 298 | N/A | N/A |
| Investments And Advances | 130 | 0 | 0 |
| Other Non-Current Assets | 56 | 0 | 0 |
| TOTAL | $484 | $N/A | $N/A |
| Total Assets | $47,944 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 901 | 0 | 0 |
| Accrued Expenses | 2,335 | N/A | N/A |
| TOTAL | $3,236 | $N/A | $N/A |
| Non-Current Liabilities | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Liabilities | $3,236 | $N/A | $N/A |
| Shareholders' Equity | |||
| Retained earnings | -34,652 | N/A | N/A |
| Other shareholders' equity | 77,932 | 0 | 0 |
| TOTAL | $44,708 | $N/A | $N/A |
| Total Liabilities And Equity | $47,944 | $0 | $0 |